GeneLink Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Net Income before Extraordinaries
2,603.50
2,716.80
2,634.70
3,830.20
3,051.70
Depreciation, Depletion & Amortization
87.10
125.60
160.50
134.80
213.00
Other Funds
-
204.30
-
954.50
-
Funds from Operations
1,891.50
2,229.20
1,740.40
3,160.50
3,068.40
Changes in Working Capital
440.60
320.30
399.90
259.40
684.80
Net Operating Cash Flow
1,450.90
2,549.50
1,340.50
2,901.10
2,383.60
Capital Expenditures
281.40
120.80
123.70
41.30
242.00
Sale of Fixed Assets & Businesses
-
-
-
-
703.60
Net Investing Cash Flow
281.40
120.80
123.70
41.30
297.30
Issuance/Reduction of Debt, Net
1.10
1,225.80
-
-
-
Net Financing Cash Flow
1,195.10
2,432.00
1,696.60
3,253.90
1,504.00
Net Change in Cash
537.20
238.30
232.40
311.50
582.30
Free Cash Flow
1,695.30
2,669.80
1,449.20
2,942.40
2,625.60
Net Assets from Acquisitions
-
-
-
-
164.40
Change in Capital Stock
1,196.30
1,410.50
1,696.60
2,299.40
1,504.00
Miscellaneous Funds
-
-
-
0.00
0.00

About GeneLink

View Profile
Address
8250 Exchange Drive
Orlando Florida 32809
United States
Employees -
Website http://www.genelinkbio.com
Updated 07/08/2019
GeneLink, Inc. engages in the development of genetics-based assessment products for pharmaceutical applications and DNA storage purpose. It also offers genetically-based nutritional supplements. The company was founded by Robert P.